僅用于工業應用或科學研究，不可用于人類或動物的臨床診斷或治療，非藥用. Fremanezumab （TEV-48125） is a humanized IgG2a monoclonal antibody that selectively and potently binds to calcitonin gene-related peptide （CGRP）. CGRP is a 37-amino acid neuropeptide involved in central and peripheral pathophysiological events of migraine. Fremanezumab has the potential for chronic migraine research